ID   MAK_HUMAN               Reviewed;         623 AA.
AC   P20794; F1T0K6; G1FL29; Q547D0; Q9NUH7;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   12-OCT-2022, entry version 194.
DE   RecName: Full=Serine/threonine-protein kinase MAK;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:12084720, ECO:0000269|PubMed:21986944};
DE   AltName: Full=Male germ cell-associated kinase;
GN   Name=MAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, INDUCTION, AUTOPHOSPHORYLATION, PHOSPHORYLATION, AND
RP   MUTAGENESIS OF LYS-33.
RC   TISSUE=Testis;
RX   PubMed=12084720; DOI=10.1074/jbc.m203940200;
RA   Xia L., Robinson D., Ma A.H., Chen H.C., Wu F., Qiu Y., Kung H.J.;
RT   "Identification of human male germ cell-associated kinase, a kinase
RT   transcriptionally activated by androgen in prostate cancer cells.";
RL   J. Biol. Chem. 277:35422-35433(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE SPLICING (ISOFORM 2),
RP   VARIANTS RP62 SER-13; ARG-27; HIS-130; HIS-166 AND THR-181,
RP   CHARACTERIZATION OF VARIANTS RP62 SER-13 AND HIS-130, AND VARIANT LEU-325.
RC   TISSUE=Retina;
RX   PubMed=21835304; DOI=10.1016/j.ajhg.2011.07.005;
RA   Ozgul R.K., Siemiatkowska A.M., Yucel D., Myers C.A., Collin R.W.,
RA   Zonneveld M.N., Beryozkin A., Banin E., Hoyng C.B., van den Born L.I.,
RA   Bose R., Shen W., Sharon D., Cremers F.P., Klevering B.J.,
RA   den Hollander A.I., Corbo J.C.;
RT   "Exome sequencing and cis-regulatory mapping identify mutations in MAK, a
RT   gene encoding a regulator of ciliary length, as a cause of retinitis
RT   pigmentosa.";
RL   Am. J. Hum. Genet. 89:253-264(2011).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE SPLICING (ISOFORM 2),
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INVOLVEMENT IN RP62.
RC   TISSUE=Retina;
RX   PubMed=21825139; DOI=10.1073/pnas.1108918108;
RA   Tucker B.A., Scheetz T.E., Mullins R.F., DeLuca A.P., Hoffmann J.M.,
RA   Johnston R.M., Jacobson S.G., Sheffield V.C., Stone E.M.;
RT   "Exome sequencing and analysis of induced pluripotent stem cells identify
RT   the cilia-related gene male germ cell-associated kinase (MAK) as a cause of
RT   retinitis pigmentosa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:E569-E576(2011).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Retinoblastoma;
RX   PubMed=21697133; DOI=10.1167/iovs.11-7479;
RA   Oshikawa M., Tsutsui C., Ikegami T., Fuchida Y., Matsubara M., Toyama S.,
RA   Usami R., Ohtoko K., Kato S.;
RT   "Full-length transcriptome analysis of human retina-derived cell lines
RT   ARPE-19 and Y79 using the vector-capping method.";
RL   Invest. Ophthalmol. Vis. Sci. 52:6662-6670(2011).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 121-163.
RX   PubMed=2183027; DOI=10.1128/mcb.10.5.2261-2268.1990;
RA   Matsushime H., Jinno A., Takagi N., Shibuya M.;
RT   "A novel mammalian protein kinase gene (mak) is highly expressed in
RT   testicular germ cells at and after meiosis.";
RL   Mol. Cell. Biol. 10:2261-2268(1990).
RN   [8]
RP   FUNCTION, INTERACTION WITH AR, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=16951154; DOI=10.1158/0008-5472.can-06-1636;
RA   Ma A.H., Xia L., Desai S.J., Boucher D.L., Guan Y., Shih H.M., Shi X.B.,
RA   deVere White R.W., Chen H.W., Tepper C.G., Kung H.J.;
RT   "Male germ cell-associated kinase, a male-specific kinase regulated by
RT   androgen, is a coactivator of androgen receptor in prostate cancer cells.";
RL   Cancer Res. 66:8439-8447(2006).
RN   [9]
RP   FUNCTION, INTERACTION WITH CDK20 AND FZR1, CATALYTIC ACTIVITY, COFACTOR,
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-157 AND TYR-159, AND
RP   MUTAGENESIS OF THR-157 AND TYR-159.
RX   PubMed=21986944; DOI=10.1038/onc.2011.464;
RA   Wang L.Y., Kung H.J.;
RT   "Male germ cell-associated kinase is overexpressed in prostate cancer cells
RT   and causes mitotic defects via deregulation of APC/C(CDH1).";
RL   Oncogene 31:2907-2918(2012).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-189; PRO-272; SER-384; SER-520 AND
RP   LEU-550.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Essential for the regulation of ciliary length and required
CC       for the long-term survival of photoreceptors (By similarity).
CC       Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in
CC       the transcriptional coactivation of AR. Could play an important
CC       function in spermatogenesis. May play a role in chromosomal stability
CC       in prostate cancer cells. {ECO:0000250, ECO:0000269|PubMed:12084720,
CC       ECO:0000269|PubMed:16951154, ECO:0000269|PubMed:21986944}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:12084720, ECO:0000269|PubMed:21986944};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:12084720,
CC         ECO:0000269|PubMed:21986944};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12084720, ECO:0000269|PubMed:21986944};
CC   -!- SUBUNIT: Interacts with RP1 (By similarity). Interacts with AR and
CC       CDK20. Found in a complex containing MAK, AR and NCOA3. Interacts with
CC       FZR1 (via WD repeats). {ECO:0000250, ECO:0000269|PubMed:16951154,
CC       ECO:0000269|PubMed:21986944}.
CC   -!- INTERACTION:
CC       P20794; P10275: AR; NbExp=5; IntAct=EBI-3911321, EBI-608057;
CC       P20794; Q9UM11: FZR1; NbExp=7; IntAct=EBI-3911321, EBI-724997;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome. Cytoplasm, cytoskeleton, spindle.
CC       Midbody. Cell projection, cilium, photoreceptor outer segment
CC       {ECO:0000250}. Photoreceptor inner segment. Note=Localized in both the
CC       connecting cilia and the outer segment axonemes (By similarity).
CC       Localized uniformly in nuclei during interphase, to the mitotic spindle
CC       and centrosomes during metaphase and anaphase, and also to midbody at
CC       anaphase until telophase. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P20794-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P20794-2; Sequence=VSP_042470;
CC       Name=3;
CC         IsoId=P20794-3; Sequence=VSP_042471;
CC   -!- TISSUE SPECIFICITY: Expressed in prostate cancer cell lines at
CC       generally higher levels than in normal prostate epithelial cell lines.
CC       Isoform 1 is expressed in kidney, testis, lung, trachea, and retina.
CC       Isoform 2 is retina-specific where it is expressed in rod and cone
CC       photoreceptors. {ECO:0000269|PubMed:12084720,
CC       ECO:0000269|PubMed:21825139}.
CC   -!- INDUCTION: Up-regulated by dihydrotestosterone (DHT) in androgen-
CC       sensitive LNCaP prostate cancer cells in a dose-dependent manner. Up-
CC       regulation by DHT is transient, reaching maximum levels after 24 hours
CC       and decreases slightly after 48 hours. {ECO:0000269|PubMed:12084720}.
CC   -!- PTM: Autophosphorylated. Phosphorylated on serine and threonine
CC       residues. {ECO:0000269|PubMed:12084720, ECO:0000269|PubMed:21986944}.
CC   -!- DISEASE: Retinitis pigmentosa 62 (RP62) [MIM:614181]: A retinal
CC       dystrophy belonging to the group of pigmentary retinopathies. Retinitis
CC       pigmentosa is characterized by retinal pigment deposits visible on
CC       fundus examination and primary loss of rod photoreceptor cells followed
CC       by secondary loss of cone photoreceptors. Patients typically have night
CC       vision blindness and loss of midperipheral visual field. As their
CC       condition progresses, they lose their far peripheral visual field and
CC       eventually central vision as well. {ECO:0000269|PubMed:21825139,
CC       ECO:0000269|PubMed:21835304}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF505623; AAN16405.1; -; mRNA.
DR   EMBL; JN226411; AEL29206.1; -; mRNA.
DR   EMBL; AB593146; BAJ84080.1; -; mRNA.
DR   EMBL; AL024498; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471087; EAW55283.1; -; Genomic_DNA.
DR   EMBL; M35863; AAA36195.1; -; Genomic_DNA.
DR   CCDS; CCDS4516.1; -. [P20794-1]
DR   CCDS; CCDS75398.1; -. [P20794-3]
DR   CCDS; CCDS75399.1; -. [P20794-2]
DR   PIR; B34711; B34711.
DR   RefSeq; NP_001229314.1; NM_001242385.1. [P20794-3]
DR   RefSeq; NP_001229886.1; NM_001242957.2. [P20794-2]
DR   RefSeq; NP_005897.1; NM_005906.5. [P20794-1]
DR   RefSeq; XP_011512921.1; XM_011514619.2. [P20794-2]
DR   RefSeq; XP_011512922.1; XM_011514620.2. [P20794-2]
DR   RefSeq; XP_011512924.1; XM_011514622.2. [P20794-3]
DR   RefSeq; XP_016866352.1; XM_017010863.1.
DR   RefSeq; XP_016866353.1; XM_017010864.1.
DR   AlphaFoldDB; P20794; -.
DR   SMR; P20794; -.
DR   BioGRID; 110291; 40.
DR   CORUM; P20794; -.
DR   IntAct; P20794; 35.
DR   STRING; 9606.ENSP00000346484; -.
DR   BindingDB; P20794; -.
DR   ChEMBL; CHEMBL1163106; -.
DR   iPTMnet; P20794; -.
DR   PhosphoSitePlus; P20794; -.
DR   BioMuta; MAK; -.
DR   DMDM; 13432166; -.
DR   EPD; P20794; -.
DR   jPOST; P20794; -.
DR   MassIVE; P20794; -.
DR   MaxQB; P20794; -.
DR   PaxDb; P20794; -.
DR   PeptideAtlas; P20794; -.
DR   PRIDE; P20794; -.
DR   ProteomicsDB; 53787; -. [P20794-1]
DR   ProteomicsDB; 53788; -. [P20794-2]
DR   ProteomicsDB; 53789; -. [P20794-3]
DR   Antibodypedia; 24855; 447 antibodies from 29 providers.
DR   DNASU; 4117; -.
DR   Ensembl; ENST00000313243.6; ENSP00000313021.2; ENSG00000111837.12. [P20794-1]
DR   Ensembl; ENST00000354489.7; ENSP00000346484.3; ENSG00000111837.12. [P20794-2]
DR   Ensembl; ENST00000474039.5; ENSP00000476067.1; ENSG00000111837.12. [P20794-1]
DR   Ensembl; ENST00000536370.6; ENSP00000442221.2; ENSG00000111837.12. [P20794-3]
DR   GeneID; 4117; -.
DR   KEGG; hsa:4117; -.
DR   MANE-Select; ENST00000354489.7; ENSP00000346484.3; NM_001242957.3; NP_001229886.1. [P20794-2]
DR   UCSC; uc003mzm.4; human. [P20794-1]
DR   CTD; 4117; -.
DR   DisGeNET; 4117; -.
DR   GeneCards; MAK; -.
DR   GeneReviews; MAK; -.
DR   HGNC; HGNC:6816; MAK.
DR   HPA; ENSG00000111837; Tissue enriched (retina).
DR   MalaCards; MAK; -.
DR   MIM; 154235; gene.
DR   MIM; 614181; phenotype.
DR   neXtProt; NX_P20794; -.
DR   OpenTargets; ENSG00000111837; -.
DR   Orphanet; 791; Retinitis pigmentosa.
DR   PharmGKB; PA30564; -.
DR   VEuPathDB; HostDB:ENSG00000111837; -.
DR   eggNOG; KOG0661; Eukaryota.
DR   GeneTree; ENSGT00940000156581; -.
DR   InParanoid; P20794; -.
DR   OMA; PMHQENI; -.
DR   OrthoDB; 76933at2759; -.
DR   PhylomeDB; P20794; -.
DR   TreeFam; TF328769; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   PathwayCommons; P20794; -.
DR   SignaLink; P20794; -.
DR   SIGNOR; P20794; -.
DR   BioGRID-ORCS; 4117; 15 hits in 1105 CRISPR screens.
DR   ChiTaRS; MAK; human.
DR   GeneWiki; MAK_(gene); -.
DR   GenomeRNAi; 4117; -.
DR   Pharos; P20794; Tchem.
DR   PRO; PR:P20794; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P20794; protein.
DR   Bgee; ENSG00000111837; Expressed in sperm and 115 other tissues.
DR   ExpressionAtlas; P20794; baseline and differential.
DR   Genevisible; P20794; HS.
DR   GO; GO:0005930; C:axoneme; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005929; C:cilium; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0031514; C:motile cilium; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032391; C:photoreceptor connecting cilium; IEA:Ensembl.
DR   GO; GO:0001917; C:photoreceptor inner segment; IDA:UniProtKB.
DR   GO; GO:0001750; C:photoreceptor outer segment; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; NAS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0060271; P:cilium assembly; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0042073; P:intraciliary transport; IBA:GO_Central.
DR   GO; GO:1902856; P:negative regulation of non-motile cilium assembly; IEA:Ensembl.
DR   GO; GO:1905515; P:non-motile cilium assembly; IEA:Ensembl.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; NAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell projection; Cilium; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Differentiation; Disease variant;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Retinitis pigmentosa;
KW   Serine/threonine-protein kinase; Spermatogenesis; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN           1..623
FT                   /note="Serine/threonine-protein kinase MAK"
FT                   /id="PRO_0000086284"
FT   DOMAIN          4..284
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          328..396
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          416..469
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        333..393
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        416..439
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        445..469
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        125
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         10..18
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         33
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         157
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:21986944"
FT   MOD_RES         159
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:21986944"
FT   VAR_SEQ         532
FT                   /note="A -> AEESIIKPIEKLSCNETFPEKLEDPQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:21825139,
FT                   ECO:0000303|PubMed:21835304"
FT                   /id="VSP_042470"
FT   VAR_SEQ         533..572
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:21697133"
FT                   /id="VSP_042471"
FT   VARIANT         13
FT                   /note="G -> S (in RP62; results in a complete loss of
FT                   kinase activity compared to wild-type; dbSNP:rs387906647)"
FT                   /evidence="ECO:0000269|PubMed:21835304"
FT                   /id="VAR_066988"
FT   VARIANT         27
FT                   /note="G -> R (in RP62; dbSNP:rs754916169)"
FT                   /evidence="ECO:0000269|PubMed:21835304"
FT                   /id="VAR_066989"
FT   VARIANT         130
FT                   /note="N -> H (in RP62; results in a complete loss of
FT                   kinase activity compared to wild-type; dbSNP:rs387906646)"
FT                   /evidence="ECO:0000269|PubMed:21835304"
FT                   /id="VAR_066990"
FT   VARIANT         166
FT                   /note="R -> H (in RP62; dbSNP:rs387906648)"
FT                   /evidence="ECO:0000269|PubMed:21835304"
FT                   /id="VAR_066991"
FT   VARIANT         181
FT                   /note="I -> T (in RP62; dbSNP:rs750559316)"
FT                   /evidence="ECO:0000269|PubMed:21835304"
FT                   /id="VAR_066992"
FT   VARIANT         189
FT                   /note="I -> V (in dbSNP:rs56215624)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042006"
FT   VARIANT         272
FT                   /note="R -> P (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042007"
FT   VARIANT         325
FT                   /note="P -> L (in dbSNP:rs371971492)"
FT                   /evidence="ECO:0000269|PubMed:21835304"
FT                   /id="VAR_066993"
FT   VARIANT         329
FT                   /note="D -> E (in dbSNP:rs17579447)"
FT                   /id="VAR_053932"
FT   VARIANT         384
FT                   /note="N -> S (in dbSNP:rs55773478)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042008"
FT   VARIANT         520
FT                   /note="P -> S (in dbSNP:rs567083)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042009"
FT   VARIANT         550
FT                   /note="F -> L (in dbSNP:rs56217305)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042010"
FT   MUTAGEN         33
FT                   /note="K->R: Abolishes autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:12084720"
FT   MUTAGEN         157
FT                   /note="T->A: Abolishes autophosphorylation and impairs
FT                   kinase activity."
FT                   /evidence="ECO:0000269|PubMed:21986944"
FT   MUTAGEN         159
FT                   /note="Y->F: Abolishes autophosphorylation and impairs
FT                   kinase activity."
FT                   /evidence="ECO:0000269|PubMed:21986944"
SQ   SEQUENCE   623 AA;  70581 MW;  67F540266F370285 CRC64;
     MNRYTTMRQL GDGTYGSVLM GKSNESGELV AIKRMKRKFY SWDECMNLRE VKSLKKLNHA
     NVIKLKEVIR ENDHLYFIFE YMKENLYQLM KDRNKLFPES VIRNIMYQIL QGLAFIHKHG
     FFHRDMKPEN LLCMGPELVK IADFGLAREL RSQPPYTDYV STRWYRAPEV LLRSSVYSSP
     IDVWAVGSIM AELYMLRPLF PGTSEVDEIF KICQVLGTPK KSDWPEGYQL ASSMNFRFPQ
     CVPINLKTLI PNASNEAIQL MTEMLNWDPK KRPTASQALK HPYFQVGQVL GPSSNHLESK
     QSLNKQLQPL ESKPSLVEVE PKPLPDIIDQ VVGQPQPKTS QQPLQPIQPP QNLSVQQPPK
     QQSQEKPPQT LFPSIVKNMP TKPNGTLSHK SGRRRWGQTI FKSGDSWEEL EDYDFGASHS
     KKPSMGVFKE KRKKDSPFRL PEPVPSGSNH STGENKSLPA VTSLKSDSEL STAPTSKQYY
     LKQSRYLPGV NPKKVSLIAS GKEINPHTWS NQLFPKSLGP VGAELAFKRS NAGNLGSYAT
     YNQSGYIPSF LKKEVQSAGQ RIHLAPLNAT ASEYTWNTKT GRGQFSGRTY NPTAKNLNIV
     NRAQPIPSVH GRTDWVAKYG GHR
//
